Centene Corp. Hits New 52-Week High at $68.41, Marking Major Milestone

Centene Corp., a prominent player in the healthcare services industry, has reached a significant milestone by hitting a new 52-week high of USD 68.41. This achievement marks a notable moment for the mid-cap company, which has a market capitalization of USD 16,287 million. Despite the recent uptick in stock price, Centene's one-year performance reflects a decline of 2.13%, contrasting sharply with the S&P 500's robust gain of 20.74% over the same period. The company's price-to-earnings ratio stands at 25.00, indicating its valuation relative to earnings, while its price-to-book ratio is recorded at 0.82. Centene Corp. maintains a debt-to-equity ratio of -0.14, suggesting a unique financial structure, and a return on equity of 3.30%. Notably, the company does not offer a dividend yield, which may influence its appeal to certain investors. The stock's previous 52-week low was USD 25.08, highlighting the significant upward movement in its price trajectory.